← Back to Search

Enhanced Support vs Standard Advice for Smoking Cessation in Veterans

N/A

Waitlist Available

Led By Jessica Megan Cook, PhD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be at least 18 years old

Not willing to set a quit date in the next 30 days

Must not have

Unable to give informed, voluntary consent to participate

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

No Placebo-Only Group

Summary

This trial will test whether Enhanced Chronic Care, which provides ongoing support to quit smoking, is more effective than Standard Care, which is only advice to quit smoking once per year.

Who is the study for?

This trial is for Veterans who smoke at least 4 cigarettes daily for the past six months, are not ready to quit within the next month, and can consent to participate. It's open to those over 18 who speak English and are medically cleared for nicotine replacement therapy if needed. Women must use birth control during the study.

What is being tested?

The trial compares Enhanced Chronic Care—a motivational support system designed to increase readiness to stop smoking—with Standard Care, which involves brief yearly advice. The goal is to see if Enhanced Chronic Care boosts treatment usage and helps participants quit smoking more effectively than Standard Care.

What are the potential side effects?

There may be no direct side effects from participating in this trial since it focuses on counseling methods rather than medication. However, individuals using nicotine replacement as part of their cessation treatment might experience typical side effects like nausea or skin irritation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am not ready to quit smoking within the next 30 days.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am unable to understand or agree to the study's procedures and risks.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

7-Day Point-Prevalence Abstinence

Secondary study objectives

Initiating at least 1 cessation treatment call

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Enhanced Chronic CareExperimental Treatment1 Intervention

Enhanced Chronic Care provides ongoing, phone-based motivational interventions and interpersonal support to promote readiness to quit, with facilitated access to evidence-based smoking treatment.

Group II: Standard CareActive Control1 Intervention

Standard Care provides phone-based brief advice to quit once per year.

0 / 3Eligibility criteria met